Sara I Pai

Author PubWeight™ 48.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 2013 5.71
2 Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res 2013 2.81
3 Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck 2008 1.97
4 Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol 2013 1.63
5 Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol 2011 1.54
6 Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 2002 1.53
7 Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res 2007 1.43
8 The impact of molecular testing on the surgical management of patients with thyroid nodules. Ann Surg Oncol 2014 1.43
9 Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 2009 1.38
10 Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 2009 1.27
11 Activation of Akt as a mechanism for tumor immune evasion. Mol Ther 2008 1.22
12 Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. Am J Surg Pathol 2013 1.19
13 HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol 2012 1.14
14 Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine. Cancer Immunol Immunother 2012 1.10
15 Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev 2002 1.09
16 Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity. Cancer Res 2010 0.99
17 Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration. World J Surg 2012 0.94
18 Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma. Cancer 2013 0.94
19 Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors. Clin Cancer Res 2013 0.92
20 Epidemiology of head and neck squamous cell cancer among HIV-infected patients. J Acquir Immune Defic Syndr 2014 0.90
21 In-situ tumor vaccination: Bringing the fight to the tumor. Hum Vaccin Immunother 2015 0.90
22 Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma. Head Neck 2011 0.89
23 Immunotherapy for head and neck cancer. J Biomed Sci 2008 0.88
24 Combination of viral oncolysis and tumor-specific immunity to control established tumors. Clin Cancer Res 2009 0.88
25 Tumor size and presence of calcifications on ultrasonography are pre-operative predictors of lymph node metastases in patients with papillary thyroid cancer. J Surg Oncol 2011 0.86
26 PET/CT in the management of thyroid cancers. AJR Am J Roentgenol 2014 0.85
27 Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas. Oral Oncol 2012 0.84
28 A DNA vaccine co-expressing antigen and an anti-apoptotic molecule further enhances the antigen-specific CD8+ T-cell immune response. J Biomed Sci 2004 0.84
29 Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects. J Biomed Sci 2002 0.84
30 Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors. J Biomed Sci 2010 0.83
31 The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma. Surgery 2013 0.82
32 Characterization of human papillomavirus type 11-specific immune responses in a preclinical model. Laryngoscope 2010 0.81
33 Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2009 0.80
34 Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma. Int J Oncol 2011 0.80
35 Comparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma. Ann Surg Oncol 2012 0.80
36 Femtosecond laser treatment enhances DNA transfection efficiency in vivo. J Biomed Sci 2009 0.78
37 Differential expression of epidermal growth factor receptor in juvenile and adult-onset recurrent respiratory papillomatosis. Histopathology 2010 0.78
38 Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngol Clin North Am 2012 0.78
39 Aggressive recurrent respiratory papillomatosis in a neonate. Int J Pediatr Otorhinolaryngol 2008 0.77
40 Profile of patients with completion thyroidectomy and assessment of their suitability for outpatient surgery. Otolaryngol Head Neck Surg 2011 0.77
41 The molecular genetics of laryngeal cancer. Otolaryngol Clin North Am 2008 0.77
42 Laryngeal muscle surface receptors identified using random phage library. Laryngoscope 2005 0.76
43 Determining the extent of lateral neck dissection necessary to establish regional disease control and avoid reoperation after previous total thyroidectomy and radioactive iodine for papillary thyroid cancer. Head Neck 2011 0.76
44 Hyperfractionated radiotherapy with concurrent cisplatin/5-Fluorouracil for locoregional advanced head and neck cancer: analysis of 105 consecutive patients. Int J Otolaryngol 2012 0.75
45 Thyroid and parathyroid surgery. Preface. Otolaryngol Clin North Am 2010 0.75
46 A staged thyroidectomy approach for gastric bypass patients. Laryngoscope 2014 0.75
47 A retropharyngeal pseudoabscess in a patient with paroxysmal nocturnal hemoglobinuria. Otolaryngol Head Neck Surg 2007 0.75
48 HPV-associated head and neck cancers. Otolaryngol Clin North Am 2012 0.75
49 Mission impossible: how HPV-associated head and neck cancers escape a primed immune response. Oral Oncol 2013 0.75